Skip to content

Innoviva, Inc. INVA Total Revenue

Total Revenue at other companies

Pfizer logo
PfizerPFE
$14.45B+5.4%
Merck & Co. logo
Merck & Co.MRK
$16.29B+4.9%
AbbVie logo
AbbVieABBV
$15B+12.4%
Insmed logo
InsmedINSM
$305.96M+230%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$246.09M+87.0%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$51.72M+14.1%

Other financials

Income statement

See full
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.4B+9.7%
P/E3.5×
P/S4.1×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s total revenue?
Innoviva, Inc. (INVA) reported total revenue of $97.99M in Q1 2026.
How has Innoviva, Inc.'s total revenue changed year-over-year?
Innoviva, Inc.'s total revenue increased by 10.6% year-over-year, from $88.63M to $97.99M.
What is the long-term trend for Innoviva, Inc.'s total revenue?
Over 4 years (2021 to 2025), Innoviva, Inc.'s total revenue has grown at a 1.2% compound annual growth rate (CAGR), from $391.87M to $411.33M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.